Cornercap Investment Counsel Inc Allovir, Inc. Transaction History

Cornercap Investment Counsel Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.15 - $3.64 $1,861 - $3,152	-866 Reduced 1.31%	65,450 $140,000
Q2 2023 Aug 11, 2023	BUY	$3.17 - $5.82 $85,019 - $156,092	26,820 Added 67.91%	66,316 $225,000
Q4 2022 Feb 13, 2023	SELL	$4.7 - $9.98 $25,807 - $54,800	-5,491 Reduced 12.21%	39,496 $202,000
Q3 2022 Nov 14, 2022	BUY	$4.13 - $8.79 $47,115 - $100,276	11,408 Added 33.97%	44,987 $355,000
Q2 2022 Aug 15, 2022	BUY	$3.26 - $7.06 $109,467 - $237,067	33,579 New	33,579 $131,000

44.4M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $933M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.